Enoch Omonge
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Enoch Omonge has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Suleh
Mbagathi District Hospital
1 shared publication - Betty Shiruli
University of Nairobi, Nairobi, Kenya
1 shared publication - Fredrick C. Otieno
University of Nairobi, Nairobi, Kenya
1 shared publication - Inmaculada Aban
Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA
1 shared publication - John W. Baddley
Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore Maryland USA
1 shared publication - Mary N. Kubo
Department of Clinical Medicine and Therapeutics, East African Kidney Institute, Faculty of Health Sciences, University of Nairobi, Nairobi, Kenya
1 shared publication
Latest Publications
- Open Access
- 12 June 2017
- Published by Springer Nature in BMC Research Notes
- Vol. 10 (1) , 203
Poncet’s disease in human immunodeficiency virus: a case report
Poncet’s disease is a rare reactive polyarthritis associated with active tuberculosis and no evidence of Mycobacterium tuberculosis in the affected joint. We report a case of a 35 year old Human Immunodeficiency Virus positive Kenyan male of Kikuyu ethnicity from Kiambu County who presented to hospital with a 6 day history of bilateral knee pain and swelling, bilateral ankle pain with right ankle swelling. The patient reported 6 months history of cough and weight loss. Chest radiograph had features consistent with pulmonary tuberculosis and sputum smear was positive for acid fast bacilli. Analysis of fluid from knee effusion showed no evidence of tuberculosis. Resolution of joint swelling was seen after 3 weeks of tuberculosis chemotherapy suggesting that this was reactive arthritis following pulmonary tuberculosis in a patient infected with human immunodeficiency virus. This case represents a rare manifestation of tuberculosis presenting as a reactive arthritis. There are very few cases of Poncet’s disease reported in literature and the diagnosis of Poncet’s disease in Human Immunodeficiency Virus/tuberculosis coinfected patient is extremely uncommon. This case report has been presented to raise awareness of this unusual tuberculosis complication and review its diagnosis and treatment.
- 12 June 2017
- Published by Springer Nature in BMC Research Notes
- Vol. 10 (1) , 203
Open AccessPoncet’s disease in human immunodeficiency virus: a case report
Poncet’s disease is a rare reactive polyarthritis associated with active tuberculosis and no evidence of Mycobacterium tuberculosis in the affected joint. We report a case of a 35 year old Human Immunodeficiency Virus positive Kenyan male of Kikuyu ethnicity from Kiambu County who presented to hospital with a 6 day history of bilateral knee pain and swelling, bilateral ankle pain with right ankle swelling. The patient reported 6 months history of cough and weight loss. Chest radiograph had features consistent with pulmonary tuberculosis and sputum smear was positive for acid fast bacilli. Analysis of fluid from knee effusion showed no evidence of tuberculosis. Resolution of joint swelling was seen after 3 weeks of tuberculosis chemotherapy suggesting that this was reactive arthritis following pulmonary tuberculosis in a patient infected with human immunodeficiency virus. This case represents a rare manifestation of tuberculosis presenting as a reactive arthritis. There are very few cases of Poncet’s disease reported in literature and the diagnosis of Poncet’s disease in Human Immunodeficiency Virus/tuberculosis coinfected patient is extremely uncommon. This case report has been presented to raise awareness of this unusual tuberculosis complication and review its diagnosis and treatment.
- 1 May 2014
- Vol. 91 (5) , 145-151
MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA
To assess the clinical management and mortality associated with cryptococcal meningitis (CM) in acquired immunodeficiency syndrome (AIDS) patients in Kenya. Cryptococcal meningitis (CM) is an increasingly prevalent infection among AIDS patients and is becoming a leading cause of morbidity and mortality in Africa. The short-term prognosis and management of patients with CM may be improved by identifying factors leading to mortality in CM patients. A retrospective chart review of 76 HIV-infected CM patients admitted between August 2008 and March 2009 at Kenyatta National Hospital and Mbagathi District Hospital. Seventy six confirmed CM positive patients. Results show that 30 (40%) of 76 patients diagnosed with CM died during hospitalization after a median hospital stay of 10 days (range, 2–73 days). Significant predictors of mortality in the univariate model were Mycobacterium tuberculosis (TB) co-infection (P = 0.04), having been diagnosed with a co-morbid condition such as diabetes, oral candidiasis and hypertension (P = 0.01), and a low median CD4+ T lymphocyte count (P < 0.001). The multivariable model revealed that male sex, previous or current ART at admission and CD4+ T lymphocyte count less than 50 were significant predictors of mortality. Conversely, a minimum of two weeks of amphotericin B treatment (P < 0.001), initiation of antiretroviral therapy (ART) (P = 0.007) and monitoring of creatinine and electrolyte levels (P = 0.02) were significantly associated with survival in the univariate model. These results demonstrate the CM-associated mortality in Kenya is high and that there is an opportunity to improve the management and the short-term outcomes of hospitalized HIV positive patients with CM.
- 1 May 2014
- Vol. 91 (5) , 145-151
MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA
To assess the clinical management and mortality associated with cryptococcal meningitis (CM) in acquired immunodeficiency syndrome (AIDS) patients in Kenya. Cryptococcal meningitis (CM) is an increasingly prevalent infection among AIDS patients and is becoming a leading cause of morbidity and mortality in Africa. The short-term prognosis and management of patients with CM may be improved by identifying factors leading to mortality in CM patients. A retrospective chart review of 76 HIV-infected CM patients admitted between August 2008 and March 2009 at Kenyatta National Hospital and Mbagathi District Hospital. Seventy six confirmed CM positive patients. Results show that 30 (40%) of 76 patients diagnosed with CM died during hospitalization after a median hospital stay of 10 days (range, 2–73 days). Significant predictors of mortality in the univariate model were Mycobacterium tuberculosis (TB) co-infection (P = 0.04), having been diagnosed with a co-morbid condition such as diabetes, oral candidiasis and hypertension (P = 0.01), and a low median CD4+ T lymphocyte count (P < 0.001). The multivariable model revealed that male sex, previous or current ART at admission and CD4+ T lymphocyte count less than 50 were significant predictors of mortality. Conversely, a minimum of two weeks of amphotericin B treatment (P < 0.001), initiation of antiretroviral therapy (ART) (P = 0.007) and monitoring of creatinine and electrolyte levels (P = 0.02) were significantly associated with survival in the univariate model. These results demonstrate the CM-associated mortality in Kenya is high and that there is an opportunity to improve the management and the short-term outcomes of hospitalized HIV positive patients with CM.